Phosphate is a specific signal for induction of osteopontin gene expression

TLDR

Osteopontin, a phosphorylated glycoprotein secreted by osteoblasts during bone development, facilitates cell attachment to the extracellular matrix and is implicated in calcification‑related diseases, yet its regulatory mechanisms remain poorly understood. The study aims to link osteopontin induction to alkaline phosphatase activity that generates free phosphate in the medium. The authors show that pRB and p300/CBP regulate osteoblast differentiation, linking osteopontin induction to alkaline phosphatase synthesis. Elevated free phosphate in the medium alone triggers osteopontin RNA and protein expression, explaining its normal regulation in bone and potential up‑regulation in damaged tissue.

Abstract

Osteopontin is a phosphorylated glycoprotein secreted to the mineralizing extracellular matrix by osteoblasts during bone development. It is believed to facilitate the attachment of osteoblasts and osteoclasts to the extracellular matrix, allowing them to perform their respective functions during osteogenesis. Several other functions have been suggested for this protein, and its up-regulation is associated with various disease states related to calcification, including arterial plaque formation and the formation of kidney stones. Although expression of this gene has been demonstrated in multiple tissues, its regulation is not well understood. Our previous studies on the roles of the retinoblastoma protein (pRB) and p300/CBP in the regulation of osteoblast differentiation revealed a link between osteopontin induction and the synthesis of alkaline phosphatase. In this paper, we describe results specifically linking induction of osteopontin to the enzymatic activity of alkaline phosphatase in the medium, which results in the generation of free phosphate. This elevation of free phosphate in the medium is sufficient to signal induction of osteopontin RNA and protein. The strong and specific induction of osteopontin in direct response to increased phosphate levels provides a mechanism to explain how expression of this product is normally regulated in bone and suggests how it may become up-regulated in damaged tissue.